| Q35499905 | A peptide of SPARC interferes with the interaction between caspase8 and Bcl2 to resensitize chemoresistant tumors and enhance their regression in vivo |
| Q37742975 | Advanced pancreatic ductal adenocarcinoma - Complexities of treatment and emerging therapeutic options. |
| Q35116107 | Anti-cancer role of SPARC, an inhibitor of adipogenesis |
| Q44163670 | Appearance of osteonectin-expressing fibroblastic cells in early rat stomach carcinogenesis and stomach tumors induced with N-methyl-N'-nitro-N-nitrosoguanidine |
| Q58825129 | Association of SPARC gene polymorphisms rs3210714 and rs7719521 with VEGF expression and utility of Nottingham Prognostic Index scoring in breast cancer in a sample of Egyptian women |
| Q29622882 | Basement membranes: structure, assembly and role in tumour angiogenesis |
| Q37316559 | Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis |
| Q93184896 | Capping gold nanoparticles with albumin to improve their biomedical properties |
| Q39224317 | DJ-1 promotes angiogenesis and osteogenesis by activating FGF receptor-1 signaling. |
| Q26799856 | Depot-Based Delivery Systems for Pro-Angiogenic Peptides: A Review |
| Q49036129 | Differential mRNA expression of the related extracellular matrix glycoproteins SC1 and SPARC in the rat embryonic nervous system and skeletal structure |
| Q83463350 | Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression |
| Q35795933 | Enhancing osteoconduction of PLLA-based nanocomposite scaffolds for bone regeneration using different biomimetic signals to MSCs |
| Q36225041 | Enzymatically-responsive pro-angiogenic peptide-releasing poly(ethylene glycol) hydrogels promote vascularization in vivo |
| Q44504681 | Exogenous SPARC suppresses proliferation and migration of prostate cancer by interacting with integrin β1. |
| Q28571596 | Expression of mRNA encoding extracellular matrix glycoproteins SPARC and SC1 is temporally and spatially regulated in the developing cochlea of the rat inner ear |
| Q34096360 | Gene expression profiling of cardiovascular disease models |
| Q41048589 | Generalized T2 test for genome association studies |
| Q40600872 | Identification of differentially expressed genes in models of melanoma progression by cDNA array analysis: SPARC, MIF and a novel cathepsin protease characterize aggressive phenotypes |
| Q34913566 | Identification of genes differentially expressed in benign versus malignant thyroid tumors |
| Q51139233 | Immunohistochemical Expression of TGF-β1 and Osteonectin in engineered and Ca(OH)2-repaired human pulp tissues. |
| Q33268092 | In silico whole-genome screening for cancer-related single-nucleotide polymorphisms located in human mRNA untranslated regions |
| Q49093345 | Induction of SC1 mRNA encoding a brain extracellular matrix glycoprotein related to SPARC following lesioning of the adult rat forebrain |
| Q52163879 | Large-scale screen for genes involved in gonad development. |
| Q52655164 | MicroRNA-211 suppresses prostate cancer proliferation by targeting SPARC. |
| Q27306725 | Molecular characterisation of transport mechanisms at the developing mouse blood-CSF interface: a transcriptome approach |
| Q38199932 | Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis. |
| Q53161333 | Osteocalcin and Osteonectin Expression in Canine Osteosarcoma. |
| Q56989891 | Osteogenic properties of late adherent subpopulations of human bone marrow stromal cells |
| Q36695184 | Overexpression of SPARC gene in human gastric carcinoma and its clinic-pathologic significance |
| Q37039030 | Past and future evolution in colloidal drug delivery systems. |
| Q34724407 | Pathobiology of epiretinal and subretinal membranes: possible roles for the matricellular proteins thrombospondin 1 and osteonectin (SPARC). |
| Q34632691 | Proteolytic events of wound-healing--coordinated interactions among matrix metalloproteinases (MMPs), integrins, and extracellular matrix molecules |
| Q37679943 | SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome |
| Q44118293 | SPARC stimulates the synthesis of OPG/OCIF, MMP-2 and DNA in human periodontal ligament cells |
| Q48912619 | SPARC/osteonectin, an endogenous mechanism for targeting albumin to the blood-cerebrospinal fluid interface during brain development |
| Q84879085 | SPARCL1: a potential molecule associated with tumor diagnosis, progression and prognosis of colorectal cancer |
| Q38108253 | Stromal expression of SPARC in pancreatic adenocarcinoma |
| Q35177655 | The effect of adiponectin on osteonectin gene expression by oxidized low density lipoprotein-treated vascular smooth muscle cells |
| Q33932563 | The occ1 gene is preferentially expressed in the primary visual cortex in an activity-dependent manner: a pattern of gene expression related to the cytoarchitectonic area in adult macaque neocortex. |
| Q40365989 | The relationship between SPARC expression in primary tumor and metastatic lymph node of resected pancreatic cancer patients and patients' survival. |
| Q40760254 | Toward a high-throughput approach to quantitative proteomic analysis: expression-dependent protein identification by mass spectrometry |
| Q40698834 | Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells |